Language accessibility and concordance, not LEP status itself, is the operative lever for medication-adherence disparities

Pattern statement #

Across independent studies, treatment-adherence (and related outcome) disparities for patients with limited English proficiency appear to be driven by the language accessibility of care and services rather than by LEP status as such. When an adherence-supporting service is offered only in English, LEP patients use it far less; but when language-accessible care is provided — patient–provider concordance, interpreters, or culturally/linguistically tailored education — adherence differences between language groups largely disappear, and LEP patients can even outperform English-proficient patients where support services are robust.

What is being claimed #

For health systems, the actionable lever is making adherence-relevant touchpoints language-accessible — concordant providers, interpreters, multilingual refill/self-management tools, and culturally tailored education — rather than treating LEP as an immutable patient-level risk. The pattern reframes "LEP → worse adherence" as "language-inaccessible care → worse adherence," which is modifiable. Evidence strength is now Moderate: five independent studies across diverse conditions (diabetes, HIV, ED care) and outcomes (medication-refill use, adherence, viral suppression, dietary adherence) point the same direction, though most are observational/small with self-report caveats.